Establishment Labs Holdings Inc Stock
The Establishment Labs Holdings Inc stock is trending slightly upwards today, with an increase of €0.20 (0.400%) compared to yesterday's price.
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Establishment Labs Holdings Inc.
As a result the target price of 55 € shows a slightly positive potential of 10.0% compared to the current price of 50.0 € for Establishment Labs Holdings Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Establishment Labs Holdings Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Establishment Labs Holdings Inc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at Citigroup Inc. from $49.00 to $60.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at Mizuho from $50.00 to $65.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $53.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
News
Establishment Labs Reports First Quarter 2024 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction